Cocaine Use Disorders and Serum Magnesium Profile

被引:1
|
作者
Tonioni, F. [1 ]
Martinotti, G. [1 ]
Barra, A. [1 ]
Martinelli, D. [1 ]
Autullo, G. [1 ]
Rinaldi, C. [1 ]
Tedeschi, D. [1 ]
Janiri, L. [1 ]
Bria, P. [1 ]
机构
[1] Catholic Univ, Sch Med, Dept Psychiat, Rome, Italy
关键词
Magnesium; Cocaine; Psychopathology; Craving; STRUCTURED CLINICAL INTERVIEW; MAJOR DEPRESSED-PATIENTS; ASPARTATE HYDROCHLORIDE; ERYTHROCYTE MAGNESIUM; CALCIUM; SYMPTOMS; PLASMA; PATHOPHYSIOLOGY; SCHIZOPHRENIA; PREFERENCE;
D O I
10.1159/000218078
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: Magnesium influences the nervous system via its actions on the release and metabolism of neurotransmitters, and abnormal magnesium metabolism has been implicated in several neuropsychiatric disorders with prominent mood symptoms. The aim of this study was to compare the serum levels of magnesium of cocaine addicts to those of heroin addicts and normal controls. We also attempted to clarify the relationship between the pathophysiology of cocaine abuse and magnesium levels by investigating their association with various clinical dimensions. Methods: Eighty-five consecutive subjects with a history of cocaine or opiate use disorders were recruited, evaluated and compared with 100 controls. The cocaine and heroin abusers were assessed with a 10-cm Visual Analogue Scale, the Symptom Check List-90 Revised, the Brown-Goodwin Scale, and the Barrat Impulsiveness Scale. Results: Magnesium levels were higher in the cocaine group compared to the opiate group and control. Male subjects had lower magnesium levels than the females of all three groups. Scores of impulsiveness, aggressiveness, craving and psychiatric symptomatology were not significantly different between the opiate and cocaine addicts. Discussion: This is the first study evaluating the magnesium level in cocaine addicts. Cocaine addicts showed higher total plasma magnesium levels than opiate addicts and normal controls, even though they remained in the normal range. The roles of the psychiatric comorbidity, of a pharmacokinetic association and of a pharmacodynamic interaction are discussed. Further prospective studies comparing serum levels of cocaine at different times are needed. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:159 / 164
页数:6
相关论文
共 50 条
  • [41] Proteomic profile of serum from patients with schizophrenia spectrum disorders
    Dmitrieva, Elena
    Smirnova, Liudmila
    Seregin, Alexander
    Zgoda, Victor
    Semke, Arkadij
    Ivanova, Svetlana
    PEERJ, 2022, 10
  • [42] Serum lipid profile in patients with oral potentially malignant disorders
    Ramaswamy, P.
    Kiran, Ch Sai
    Raju, B. Mrudula
    Swathi, M.
    Anusha, A.
    Sharanya, Goteti Elizabeth
    JOURNAL OF INDIAN ACADEMY OF ORAL MEDICINE AND RADIOLOGY, 2019, 31 (04) : 323 - 327
  • [43] Adenosine A2AReceptors in Substance Use Disorders: A Focus on Cocaine
    Wydra, Karolina
    Gawlinski, Dawid
    Gawlinska, Kinga
    Frankowska, Malgorzata
    Borroto-Escuela, Dasiel O.
    Fuxe, Kjell
    Filip, Malgorzata
    CELLS, 2020, 9 (06)
  • [44] Preclinical support for the therapeutic potential of zolmitriptan as a treatment for cocaine use disorders
    Raul Garcia
    Tien Le
    Samantha N. Scott
    Delaram Charmchi
    Jamie M.L. Sprout
    Nathan S. Pentkowski
    Janet L. Neisewander
    Translational Psychiatry, 10
  • [45] Emotion Processing and Cognition in Comorbid Psychosis Spectrum and Cocaine Use Disorders
    Norbury, Agnes
    Liu, Shelley
    Shanahan, Megan
    Ramjas, Elizabeth
    Rutter, Sarah
    Larsen, Emmett
    Smith, Emma
    Grasso, Jesse
    Chan, Chi
    Cipriani, Nicolo
    Ospina, Luz
    Alia-Klein, Nelly
    Goldstein, Rita Z.
    Burdick, Katherine E.
    Perez-Rodriguez, M. Mercedes
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 339 - 340
  • [46] Preclinical support for the therapeutic potential of zolmitriptan as a treatment for cocaine use disorders
    Garcia, Raul
    Le, Tien
    Scott, Samantha N.
    Charmchi, Delaram
    Sprout, Jamie M. L.
    Pentkowski, Nathan S.
    Neisewander, Janet L.
    TRANSLATIONAL PSYCHIATRY, 2020, 10 (01)
  • [47] ZINC, COPPER AND MAGNESIUM CONCENTRATION IN SERUM AND CSF OF PATIENTS WITH NEUROLOGICAL DISORDERS
    KAPAKI, E
    SEGDITSA, J
    PAPAGEORGIOU, C
    ACTA NEUROLOGICA SCANDINAVICA, 1989, 79 (05): : 373 - 378
  • [48] Relationships between impulsivity, alexithymia and negative affectivity in cocaine use disorders
    Cyr, Laura
    Bernard, Laura
    Pedinielli, Jean-Louis
    Cutarella, Christophe
    Brejard, Vincent
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2023, 58 : 18 - 18
  • [49] Comorbid bipolar and cocaine use disorders increase the risk for HIV and AIDS
    CostantiniFerrando, M
    Holland, JC
    PSYCHOSOMATICS, 1997, 38 (02) : 16 - 16
  • [50] Psychometric assessment of motives for using cocaine in men with substance use disorders
    Ward, LC
    Kersh, BC
    Shanks, D
    PSYCHOLOGICAL REPORTS, 1997, 80 (01) : 189 - 190